CEFOPERAZONE

CEFOPERAZONE

(6R,7R)-7-((2-((4-Ethyl-2,3-dioxo-piperazine-1-carbonyl)amino)-2-(4-hydroxyphenyl)acetyl)amino)-3-((1-methyltetrazol-5-yl)sulfanylmethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; Cefoperazone; Cefobid; Cefoperazonum; Cefoperazono; (6R,7R)-7-((R)-2-(4-Ethyl-2,3-dioxo-1-piperazinylcarboxamido)-2-(4-hydroxyphenyl)acetamido)-3-((1-methyl-1H-tetrazol-5-yl)thiomethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-2-carboxylic acid; (6R-(6-alpha,7-beta(R')))-7-(((((4-Ethyl-2,3-dioxo-1-piperazinyl)carbonyl)amino)(4-hydroxyphenyl)acetyl)amino)-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid;

CAS RN	:	62893-19-0
EINECS RN	:	263-749-4
FORMULA	:	C₂₅H₂₇N₉O₈S₂
MASS	:	645.67
DESCRIPTION	:	A 3rd generation cephalosporin; beta-Lactamase resistant with tetrazolyl moiety. Active against a broad-spectrum of aerobic and anaerobic gram-positive and gram-negative bacteria. beta-Lactamase is produced by many gram-negative bacteria. The stability to beta-lactamases increases the activity against gram-negative organisms.